Erhei Dai

2.9k total citations · 1 hit paper
96 papers, 1.7k citations indexed

About

Erhei Dai is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Erhei Dai has authored 96 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Infectious Diseases, 39 papers in Epidemiology and 20 papers in Molecular Biology. Recurrent topics in Erhei Dai's work include Hepatitis B Virus Studies (25 papers), SARS-CoV-2 and COVID-19 Research (23 papers) and Hepatitis C virus research (17 papers). Erhei Dai is often cited by papers focused on Hepatitis B Virus Studies (25 papers), SARS-CoV-2 and COVID-19 Research (23 papers) and Hepatitis C virus research (17 papers). Erhei Dai collaborates with scholars based in China, United States and Belarus. Erhei Dai's co-authors include Calvin Q. Pan, Huaibin Zou, Yuming Wang, Hongxiu Jiang, Guorong Han, Shuqin Zhang, Wenjing Zhao, Huaihong Zhang, Zhongping Duan and Zhaobiao Guo and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Erhei Dai

90 papers receiving 1.7k citations

Hit Papers

Tenofovir to Prevent Hepatitis B Transmission in Mothers ... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
    2016 386 citations Calvin Q. Pan, Zhongping Duan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erhei Dai China 21 714 570 524 477 310 96 1.7k
Rob Striker United States 26 563 0.8× 599 1.1× 721 1.4× 340 0.7× 363 1.2× 66 2.3k
Gudrun Holland Germany 21 484 0.7× 621 1.1× 646 1.2× 75 0.2× 141 0.5× 49 1.6k
Ka‐Cheung Luk United States 18 713 1.0× 1.4k 2.4× 575 1.1× 840 1.8× 248 0.8× 40 3.1k
Munir Iqbal United Kingdom 29 1.8k 2.5× 1.1k 2.0× 609 1.2× 142 0.3× 212 0.7× 113 3.0k
Yoshikazu Honda‐Okubo Australia 20 576 0.8× 524 0.9× 354 0.7× 74 0.2× 52 0.2× 67 1.5k
Jérôme Bouquet United States 17 238 0.3× 470 0.8× 349 0.7× 214 0.4× 51 0.2× 24 1.1k
Hiroshi Katoh Japan 15 332 0.5× 1.3k 2.4× 440 0.8× 67 0.1× 99 0.3× 38 1.9k
German A. Shipulin Russia 21 313 0.4× 761 1.3× 372 0.7× 96 0.2× 137 0.4× 185 1.7k
Michelle Nelson United Kingdom 21 850 1.2× 450 0.8× 221 0.4× 42 0.1× 86 0.3× 52 1.5k
Kai Dallmeier Belgium 23 396 0.6× 1.5k 2.7× 296 0.6× 538 1.1× 98 0.3× 72 2.2k

Countries citing papers authored by Erhei Dai

Since Specialization
Citations

This map shows the geographic impact of Erhei Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erhei Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erhei Dai more than expected).

Fields of papers citing papers by Erhei Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erhei Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erhei Dai. The network helps show where Erhei Dai may publish in the future.

Co-authorship network of co-authors of Erhei Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Erhei Dai. A scholar is included among the top collaborators of Erhei Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erhei Dai. Erhei Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Lijing, Yuling Wang, Jianhua Lu, et al.. (2025). Near-Full-Length Genomic Characterization of Two Novel HIV-1 Unique Recombinants (CRF01_AE/CRF07_BC) and (CRF01_AE/CRF68_01B) in Shijiazhuang, Hebei Province, China. AIDS Research and Human Retroviruses. 41(6). 305–311.
3.
4.
Song, Xuedong, Huixia Gao, Yanyan Xie, et al.. (2024). Prevalence of infection and reinfection among health care workers in a hospital of Northern China between BA.5/BF.7 and XBB.1.5 wave. American Journal of Infection Control. 53(2). 228–238. 1 indexed citations
5.
Li, Yang, et al.. (2024). Pollutants-mediated viral hepatitis in different types: assessment of different algorithms and time series models. Scientific Reports. 14(1). 21141–21141. 2 indexed citations
6.
Song, Xuedong, Xuejun Wang, Yu-Wei Zhang, et al.. (2024). Finite immune imprinting on neutralizing antibody responses to Omicron subvariants by repeated vaccinations. International Journal of Infectious Diseases. 147. 107198–107198. 2 indexed citations
7.
Jiang, Xiaolin, Xuedong Song, Xuejun Wang, et al.. (2024). Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection. Cell Reports. 43(7). 114387–114387. 5 indexed citations
8.
Li, Jinzhong, Maggie Z. X. Xiao, Li Ni, et al.. (2024). Spatial and Single‐Cell Transcriptomics Reveals the Regional Division of the Spatial Structure of MASH Fibrosis. Liver International. 45(4). e16125–e16125. 8 indexed citations
9.
10.
Pan, Calvin Q., Erhei Dai, Hua Zhang, et al.. (2024). Tenofovir and Hepatitis B Virus Transmission During Pregnancy. JAMA. 333(5). 390–390. 6 indexed citations
11.
Zhu, Ka-Li, Xiaolin Jiang, Xuejun Wang, et al.. (2023). Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection. Cell Reports. 42(2). 112075–112075. 14 indexed citations
12.
Liang, Shaohui, Huixia Gao, Tongxin He, et al.. (2023). Association between SUMF1 polymorphisms and COVID-19 severity. BMC Genomic Data. 24(1). 34–34. 1 indexed citations
13.
Zhu, Ka-Li, Huixia Gao, Yao Lin, et al.. (2022). Delta Infection After Vaccination Elicits Potent Neutralizing Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron. The Journal of Infectious Diseases. 226(9). 1551–1555. 4 indexed citations
14.
Xu, Yanan, Ying Jing, Lingfei Hu, et al.. (2022). IncFIB-4.1 and IncFIB-4.2 Single-Replicon Plasmids: Small Backbones with Large Accessory Regions. SHILAP Revista de lepidopterología. 6 indexed citations
15.
Wang, Xuejun, Yao Lin, Hong‐Yun Zhang, et al.. (2022). Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants. Genome Medicine. 14(1). 146–146. 14 indexed citations
16.
Wang, Chongwen, Dawei Shi, Nan Chi Wan, et al.. (2021). Development of spike protein-based fluorescence lateral flow assay for the simultaneous detection of SARS-CoV-2 specific IgM and IgG. The Analyst. 146(12). 3908–3917. 48 indexed citations
17.
You, Yue, Xiaoming Cui, Huixia Gao, et al.. (2021). Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients. Signal Transduction and Targeted Therapy. 6(1). 342–342. 30 indexed citations
18.
Xing, Ying, Lijing Wang, Hanping Li, et al.. (2021). Identification of Two Novel HIV-1 Second-Generation Recombinant Forms (CRF01_AE/CRF07_BC) in Hebei, China. AIDS Research and Human Retroviruses. 37(12). 967–972. 9 indexed citations
19.
Pan, Calvin Q., Zhongping Duan, Erhei Dai, et al.. (2016). Tenofovir to Prevent Hepatitis B Transmission in Mothers With High Viral Load. Obstetrical & Gynecological Survey. 71(10). 586–587. 3 indexed citations
20.
Dai, Erhei. (2003). Genotyping of HBV sequences in DDBJ database by phylogenetic analysis. Letters in Biotechnology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rob Striker Breakdown of academic impact, for papers by Gudrun Holland Breakdown of academic impact, for papers by Ka‐Cheung Luk Breakdown of academic impact, for papers by Munir Iqbal Breakdown of academic impact, for papers by Yoshikazu Honda‐Okubo Breakdown of academic impact, for papers by Jérôme Bouquet Breakdown of academic impact, for papers by Hiroshi Katoh Breakdown of academic impact, for papers by German A. Shipulin Breakdown of academic impact, for papers by Michelle Nelson Breakdown of academic impact, for papers by Kai Dallmeier
Rankless by CCL
2026